LONDON (AFX) - Generic drug maker Hikma Pharmaceuticals PLC has agreed to buy Germany’s Ribosepharm, which specialises in selling and marketing cancer treatments, for 45 mln usd.
LONDON (AFX) - Generic drug maker Hikma Pharmaceuticals PLC has agreed to buy Germany’s Ribosepharm, which specialises in selling and marketing cancer treatments, for 45 mln usd.
